PUBLISHED: JULY 2020
2015 – 2025 GLOBAL LIVER CANCER THERAPEUTICS MARKET BY CANCER TYPE, BY THERAPY, BY EQUIPMENT, BY AGE, BY FACTORS, BY ROUTE OF ADMINISTRATION, BY DISTRIBUTION CHANNEL, BY REGION,
MARKET
INTELLIGENCE
.
CONSULTING
© TechSci Research
COMPETITION, FORECAST AND OPPORTUNITIES
www.techsciresearch.com 1
Product Overview Liver cancer is the sixth most commonly diagnosed malignancy globally. HCC is the most common subtype (~70-90%) and is associated with chronic HBV/HCV infection. Major drivers for global liver cancer therapeutics market is increasing aging population, government focus on public health infrastructure, rising occurrences of cancer and mounting health expenditure. However, factors such as stringent regulatory processes, high capital investments, low success rate in clinical trials are hindering the growth of the global liver cancer therapeutics market. Pharma players are using various strategies of mergers and acquisitions, development of novel products and new techniques for diagnosis of liver cancer which will further drive the growth of the market over the forecast period.
Market Segmentation Global Liver Cancer Therapeutics Market
By Cancer Type
By Age
•
Hepatocellular Carcinoma
•
50+
•
Cholangiocarcinoma
•
35-50
•
Hepatoblastoma
•
18-35
•
Angiosarcoma
•
0-18
•
Liver Metastasis
By Factors
By Therapy •
Chemotherapy and Radiation
•
Targeted Therapy
•
Immunotherapy
•
Others
By Equipment
•
Cirrhosis
•
Excessive Alcohol
By Distribution Channel •
Hospital Pharmacies
•
Retail Pharmacies
•
Online Pharmacies
Consumption •
Non-alcoholic Fatty Liver Disease and Diabetes
•
Year Range Base Year
2019 Estimated Year
2020 Forecast Period
2021-2025
Others
•
Computed Radiography
By Route of Administration
•
Sonography
•
Oral
•
MRI
•
Intravenous
•
Others
•
Others © TechSci Research
2
Table of Contents S. No.
Contents
1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
Global Liver Cancer Therapeutics Market Outlook Market Size & Forecast 5.1.1. 5.2.
5.3.
By Value
Market Share & Forecast
5.2.1.
By Cancer Type (Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblasoma, Angiosarcoma, Liver Metastasis)
5.2.2.
By Therapy (Chemotherapy & Radiation, Target Therapy, Immunotherapy, Others)
5.2.3.
By Equipment (Computed Radiography, Sonography, MRI, Others)
5.2.4.
By Age (50+, 35-50, 18-35,0-18)
5.2.5
By Factors (Cirrhosis, Excusive Alcohol Consumptions, Non-alcoholic Fatty Liver Diseases & Diabetes, Others)
5.2.6.
By Route of Administration (Oral, Intravenous, Others)
5.2.7.
By Distribution Channel (Hospitals, Retail, Online)
5.2.8.
By Region (Asia Pacific, Europe, North America, South America, Middle East & Africa)
5.2.9.
By Company (2019)
Product Map
Š TechSci Research
5.1.
Table of Contents S. No.
Asia Pacific Liver Cancer Therapeutics Market Outlook 6.1.
Market Size & Forecast 6.1.1.
6.2.
By Value
Market Share & Forecast 6.2.1.
By Cancer Type
6.2.2.
By Therapy
6.2.3.
By Equipment
6.2.4
By Age
6.2.5.
By Factors
6.2.6.
By Route of Administration
6.2.7.
By Country (China, India, Japan, South Korea, Singapore, Australia)
6.3.
Asia-Pacific: Country Analysis
6.4.
Japan Liver Cancer Therapeutics Market Outlook 6.4.1.
Market Size & Forecast 6.4.1.1.
6.4.2.
By Value
Market Share & Forecast
Š TechSci Research
6.
Contents
Table of Contents S. No.
Contents
By Cancer Type
6.4.2.2.
By Therapy
6.4.2.3.
By Equipment
6.4.2.4.
By Age
6.4.2.5.
By Factors
6.4.2.6.
By Route OF Administration
China Liver Cancer Therapeutics Market Outlook 6.5.1.
Market Size & Forecast 6.5.1.1.
6.5.2.
6.6.
By Value
Market Share & Forecast 6.5.2.1.
By Cancer Type
6.5.2.2.
By Therapy
6.5.2.3.
By Equipment
6.5.2.4.
By Age
6.5.2.5.
Factors
6.5.2.6.
By Route of Administration
India Liver Cancer Therapeutics Market Outlook 6.6.1.
Market Size & Forecast
6.6.1.1.
By Value
© TechSci Research
6.5.
6.4.2.1
Table of Contents S. No.
Contents
Market Share & Forecast
6.6.2.1.
By Cancer Type
6.6.2.2.
By Therapy
6.6.2.3.
By Equipment
6.6.2.4.
By Age
6.6.2.5.
By Factors
6.6.2.6.
By Route of Administration
South Korea Liver Cancer Therapeutics Market Outlook 6.7.1.
Market Size & Forecast 6.7.1.1.
6.7.2.
6.8
By Value
Market Share & Forecast 6.7.2.1.
By Cancer Type
6.7.2.2.
By Therapy
6.7.2.3.
By Equipment
6.7.2.4.
By Age
6.7.2.5.
By Factors
6.7.2.6.
By Route of Administration
Australia Liver Cancer Therapeutics Market Outlook 6.8.1.
Market Size & Forecast
© TechSci Research
6.7.
6.6.2.
Table of Contents S. No.
Contents 6.8.1.1. 6.8.2
Market Share & Forecast 6.8.2.1.
By Cancer Type
6.8.2.2
By Therapy
6.8.2.3.
By Equipment
6.8.2.4.
By Age
6.8.2.5.
By Factors
6.8.2.6.
By Route of Administration
Europe Liver Cancer Therapeutics Market Outlook 7.1.
Market Size & Forecast 7.1.1.
7.2
By Value
Market Share & Forecast 7.2.1.
By Cancer Type
7.2.2.
By Therapy
7.2.3.
By Equipment
7.2.4.
By Age
7.2.5.
By Factors
7.2.6.
By Route of Administration
7.2.7.
By Country (United Kingdom, Italy, France, Germany, Spain)
© TechSci Research
7.
By Value
Table of Contents S. No.
Contents 7.3.
Europe: Country Analysis
7.4
Germany Liver Cancer Therapeutics Market Outlook 7.4.1.
Market Size & Forecast 7.4.1.1.
7.4.2.
Market Share & Forecast 7.4.2.1.
By Cancer Type
7.4.2.2.
By Therapy
7.4.2.3.
By Equipment
7.4.2.4.
By Age
7.4.2.5.
By Factors
7.4.2.6.
By Route of Administration
France Liver Cancer Therapeutics Market Outlook 7.5.1.
Market Size & Forecast
7.5.1.1. 7.5.2.
By Value
Market Share & Forecast 7.5.2.1.
By Cancer Type
7.5.2.2.
By Therapy
7.5.2.3.
By Equipment
7.5.2.4.
By Age
Š TechSci Research
7.5
By Value
Table of Contents S. No.
Contents By Factors
7.5.2.6.
By Route of Administration
United Kingdom Liver Cancer Therapeutics Market Outlook
7.5.1.
Market Size & Forecast 7.5.1.1.
7.5.2.
7.7.
By Value
Market Share & Forecast 7.5.2.1.
By Cancer Type
7.5.2.2.
By Therapy
7.5.2.3.
By Equipment
7.5.2.4.
By Age
7.5.2.5.
By Factors
7.5.2.6.
By Route of Administration
Italy Liver Cancer Therapeutics Market Outlook 7.6.1.
Market Size & Forecast 7.6.1.1
7.7.2.
By Value
Market Share & Forecast 7.7.2.1.
By Cancer Type
7.7.2.2.
By Therapy
Š TechSci Research
7.6
7.5.2.5.
Table of Contents S. No.
Contents
7.8.
7.7.2.3.
By Equipment
7.7.2.4.
By Age
7.7.2.5.
By Factor
7.7.2.6.
By Route of Administration
Spain Liver Cancer Therapeutics Market Outlook 7.8.1.
Market Size & Forecast 7.8.1.1.
7.8.2.
Market Share & Forecast 7.8.2.1.
By Cancer Type
7.8.2.2.
By Therapy
7.8.2.3.
By Equipment
7.8.2.4.
By Age
7.8.2.5.
By Factors
7.8.2.6.
By Route of Administration
North America Liver Cancer Therapeutics Market Outlook 8.1
Market Size & Forecast 8.1.1
8.2
By Value
Market Share & Forecast 8.2.1
By Cancer Type
8.2.2
By Therapy
© TechSci Research
8.
By Value
Table of Contents S. No.
Contents 8.2.3.
By Equipment
8.2.4.
By Age
8.2.5
By Factors
8.2.6.
By Route of Administration
8.2.7.
By Country (USA, Mexico, Canada)
8.3.
North America: Country Analysis
8.4.
United States Liver Cancer Therapeutics Market Outlook 8.4.1.
Market Size & Forecast 8.5.1.1.
8.4.2.
Market Share & Forecast 8.4.2.1.
By Cancer Type
8.4.2.2.
By Therapy
8.4.2.3.
By Equipment
8.4.2.4.
By Age
8.4.2.5.
By Factors
8.4.2.6.
By Route of Administration
Canada Liver Cancer Therapeutics Market Outlook
8.5.1.
Market Size & Forecast 8.5.1.1.
8.5.2.
By Value
Market Share & Forecast 8.5.2.1
By Product
© TechSci Research
8.5.
By Value
Table of Contents S. No.
Contents
8.6.
8.5.2.2.
By Therapy
8.5.2.3.
By Equipment
8.5.2.4.
By Age
8.5.2.5.
By Factors
8.5.2.6.
By Route of Administration
Mexico Liver Cancer Therapeutics Market Outlook 8.6.1
Market Size & Forecast 8.6.1.1.
8.6.2.
Market Share & Forecast 8.6.2.1.
By Cancer Type
8.6.2.2.
By Therapy
8.6.2.3.
By Equipment
8.6.2.4.
By Age
8.6.2.5.
By Factors
8.6.2.6.
By Route of Administration
South America Liver Cancer Therapeutics Market Outlook 9.1.
Market Size & Forecast 9.1.1
By Value
© TechSci Research
9
By Value
Table of Contents S. No.
Contents Market Share & Forecast 9.2.1
By Cancer Type
9.2.2
By Therapy
9.2.3
By Equipment
9.2.4
By Age
9.2.5.
By Factors
9.2.6.
By Route of Administration
9.2.7.
By Country (Brazil, Argentina, Colombia, Rest of South America)
9.3.
South America: Country Analysis
9.4.
Brazil Liver Cancer Therapeutic Market Outlook 9.4.1.
Market Size & Forecast 9.4.1.1.
9.4.2.
By Value
Market Share & Forecast 9.4.2.1.
By Cancer Type
9.4.2.2.
By Therapy
9.4.2.3.
By Equipment
9.4.2.4.
By Age
9.4.2.5.
By Factors
9.4.2.6.
By Route of Administration
© TechSci Research
9.2
Table of Contents S. No.
Contents 9.5. Argentina Liver Cancer Therapeutics Market Outlook 9.5.1.
Market Size & Forecast 9.5.1.1.
9.5.2.
Market Share & Forecast 9.5.2.1.
By Cancer Type
9.5.2.2.
By Therapy
9.5.2.3.
By Equipment
9.5.2.4.
By Age
9.5.2.5.
By Factors
9.5.2.6.
By Route of Administration
Colombia Liver Cancer Therapeutics Market Outlook 9.6.1.
Market Size & Forecast 9.6.1.1.
9.6.2.
By Value
Market Share & Forecast 9.6.2.1.
By Cancer Type
9.6.2.2.
By Therapy
9.6.2.3.
By Equipment
9.6.2.4.
By Age
9.6.2.5.
By Factors
Š TechSci Research
9.6.
By Value
Table of Contents S. No.
Middle East & Africa Liver Cancer Therapeutics Market Outlook
10.1.
Market Size & Forecast 10.1.1.
10.2.
By Value
Market Share & Forecast 10.2.1
By Cancer Type
10.2.2.
By Therapy
10.2.3.
By Equipment
10.2.4.
By Age
10.2.5.
By Factors
10.2.6.
By Route of Administration
10.2.2.
By Country (South Africa, Saudi Arabia, UAE, Rest of MEA)
10.3
Middle East & Africa : Country Analysis
10.4
South Africa Liver Cancer Therapeutics Market Outlook 10.4.1
Market Size & Forecast 10.4.1.1. By Value
10.4.2.
Market Share & Forecast 10.4.2.1.
By Cancer Type
© TechSci Research
10.
Contents
Table of Contents S. No.
Contents
10.5
10.4.2.2.
By Therapy
10.4.2.3.
By Equipment
10.4.2.4.
By Age
10.4.2.5.
By Factors
10.4.2.6.
By Route of Administration
Saudi Arabia Liver Cancer Therapeutics Market Outlook 10.5.1
Market Size & Forecast 10.5.1.1.
By Value
Market Share & Forecast By Cancer Type
10.5.2.2.
By Therapy
10.5.2.3.
By Equipment
10.5.2.4.
By Age
10.5.2.5.
By Factors
UAE Arabia Liver Cancer Therapeutics Market Outlook 10.6.1.
Market Size & Forecast
10.6.1.1. 10.6.2.
By Value
Market Share & Forecast 10.6.2.1.
By Cancer Type
10.6.2.2.
By Therapy
© TechSci Research
10.6
10.5.2.1.
Table of Contents S. No. 10.6.2.3.
By Equipment Equipment
10.6.2.4.
By Age
10.6.2.5
By Factors
10.6.2.6.
By Route of Administration
Market Dynamics 11.1
Drivers
11.2
Challenges
11.3
Market Trends & Developments
12.
Impact of COVID-19
13.
Competitive Landscape (Top Global Leaders) 13.1.
Merck & Co. Inc.
13.2.
F.Hoffmann-La Roche Ltd
13.3.
Bristol-Myers Squibb Company
13.4.
Bayer AG
13.5.
Novartis International AG
13.6.
Eisai Co., Ltd.
13.7
Sanofi S.A.
13.8
Eli Lilly and Company
13.9
Johnson & Johnson
13.10
Sun Pharmaceutical Industries Ltd.
© TechSci Research
11.
Contents
Table of Contents Contents 13.10
Sun Pharmaceutical Industries Ltd.
13.11
Amgen Inc
13.12
AstraZeneca
13.13
Philips Healthcare Pvt. Ltd
13.14
Pfizer Inc
13.15
Celsion Corporation
13.16
Exelixis, Inc
13.17
PerkinElmer
13.18
Alnylam Pharmaceuticals Inc
13.19
AbbVie Inc.
14.
Strategic Recommendations
15.
About Us and Disclaimer
© TechSci Research
S. No.
Research Methodology
Research Methodology
In-depth secondary research was conducted to determine top players in the global liver therapeutics market, overall market size and segmental market size.
Formulating Questionnaire
In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.
Developing List of Respondents
Data Collection
Data Validation
Data obtained as a result of primary and secondary research was validated through rigorous triangulation.
TechSci conducted interviews with industry experts and industry players for data collection and verification.
List of industry players and industry specialists was developed.
Primary Research
Data Collection
Data Filter & Analysis
Research & Intelligence
Actionable Insights
Business Solution
LinkedIn TechSci Internal Database
✓ Recent Developments ✓ Market Changing Aspects/Dynamics ✓ Government Policies ✓ Conclusion
✓ Identifying Key Opinion Leaders ✓ Questionnaire Design ✓ In-depth Interviews
Primary Research ✓ ✓
Desk Research
Secondary Research ✓ ✓ ✓ ✓ ✓ ✓
Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Bodies, Associations, etc.
Data Analysis
The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global liver therapeutics market.
Company Analysis ✓ Market Participants ✓ Key Strengths
Paid Sources
✓ ✓
Factiva Hoovers
© TechSci Research
Market Profiling
Research Methodology Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global liver cancer therapeutics market. The team has
analyzed the outlook of various segments of this market, while considering the major influencing factors such as growing incidence of liver cancer, increase in alcohol consumption, etc. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global liver cancer therapeutics market.
Methodology Followed for Calculation of Market Size:
•
Market Size by Value & Volume: Market size, in terms of value & volume, for the year 2019 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as the manufacturer of drugs used for liver cancer treatment, channel partners, market influencers & end users, industry experts, and other industry participants.
The team interviewed more than 25 – 30 liver cancer drug manufacturers, 100 – 120 end users, 20 – 25 industry experts and other value chain stakeholders in the global liver cancer therapeutics market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015-2019.
© TechSci Research
•
Research Methodology •
Respondents were asked about the current and future market growth rates, market shares by cancer type, by therapy, by equipment, by age, by factors, by route of administration, by distribution channel, by region, and by company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares: •
Market shares by cancer type, by therapy, by equipment, by age, by factors, by route of administration, by distribution channel, by equipment , by region, and by company were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of liver cancer therapeutics markets. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting: •
TechSci Research performed periodical checks on the data collected through surveys with logical checks and analyzed the results in SPSS/Tableau Software. The currency used in the report is United States Dollar (USD) and all market size numbers are indicated in USD Billion. Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global liver cancer therapeutics market, TechSci Research used various forecast techniques such as: ✓
Moving Average
✓
Regression Analysis
✓
Econometric and Judgmental Analysis
© TechSci Research
•
Research Methodology TechSci Research used its own forecast model, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and arrive at accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD Billion. Key Secondary Sources
▪
Alnylam Pharmaceuticals Inc.
•
International Monetary Fund
▪
Eisai Co., Ltd.
▪
World Bank
▪
Sanofi S.A.
▪
TechSci Research Proprietary Database & Knowledge
▪
Novartis International AG
▪
Eli Lilly and Company
▪
Company Annual Reports
▪
F.Hoffmann-La Roche Ltd
▪
Industry Magazines
▪
Johnson & Johnson
▪
Industry Reports
▪
Merck & Co. Inc.
▪
Credible Paid Databases
▪
Sun Pharmaceutical Industries Ltd.
▪
News Dailies
▪
Amgen Inc.
▪
International Committee of the Red Cross
▪
AstraZeneca
▪
World Health Organization
▪
Philips Healthcare Pvt. Ltd
▪
▪
Bayer AG
▪
American Cancer Society
▪
Pfizer Inc.
▪
Oncology Professional Organizations
▪
Celsion Corporation
▪
The Food and Drug Administration
▪
Bristol-Myers Squibb Company
▪
American Liver Foundation
▪
Exelixis, Inc
▪
International Liver Foundation
▪
PerkinElmer
▪
National Cancer Institute
▪
AbbVie Inc.
Repository
Globocan
© TechSci Research
Partial List of Companies Interviewed
Industry Brief According to TechSci Research report, “Global Liver Cancer Therapeutics Market By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Others), By Therapy (Targeted Therapy, Radiation Therapy, Immunotherapy, Chemotherapy, Others), By Equipment (Computed Radiography, Radiofrequency Equipment, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Chronic Infection with HBV Or HCV, Cirrhosis, Inherited Liver Disease, Diabetes, Others), By Route of Administration (Oral, Intra-Venous, Intra-Arterial, Intra-Tumoral, Intra-Portal, Intra-Splenic, IntraBiliary), By Region, Forecast & Opportunities, 2025”, the global liver cancer therapeutics market is expected to witness a robust CAGR during the forecast period owing to factors like rising
prevalence of liver cancer and development of novel innovative therapeutic drugs, increase in awareness among people. Liver cancer accounts for the third foremost reason for deaths associated with cancer around the world. Changes in current lifestyle increases the risk factors that contribute to liver cancer. Scientists around the world are working on research activities for developing novel treatments for liver cancer, which is forecast to drive the market for liver cancer therapeutics. However, high capital investment, stringent drug approval process, high research & development cost and adverse side-effects of cancer treatment medications are factors which might hinder the growth of liver cancer therapeutics market. The global liver cancer therapeutics market is segmented based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region. Based on cancer type, the market is segmented into hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, angiosarcoma and liver metastasis. The hepatocellular carcinoma segment accounted for the largest market share in 2019 owing to its high prevalence, especially in Asian and African nations. Based on therapy, the market is segmented into targeted therapy, radiation therapy, immunotherapy, chemotherapy, radiofrequency ablation, microwave ablation, embolization & chemoembolization and surgery. Among them, the targeted therapy is anticipated to be the largest segment until 2025 as it is the only approved targeted therapeutic treatment that is available for the treatment of the advanced stage liver cancer. This therapy uses tyrosine kinase inhibitors
which inhibit the several kinase proteins that stimulate cancer cell growth. Major players operating in the global liver cancer therapeutics market include Bayer AG, Alnylam Pharmaceuticals Inc., F. Hoffmann-La Roche AG , Bristol-Myers Squibb Co, Eisai Co., Ltd. , Pfizer Inc., Exelixis, Inc., Merck & Co. Inc., Celsion Corporation , ArQule Inc., Johnson & Johnson, Novartis, Sanofi, Eli Lily, Perkin Elmer, Sunpharma, AbbVie, Amgen, AstraZeneca, Philips Healthcare and others. The market players are focusing on research and development activities to bring innovative treatments for liver cancer. Added to this, government funding is also
“Aging population and unmet requirements for liver cancer treatment accounts for the growth of global liver cancer therapeutics market. Today, variety of treatment options are available in the market. However, increasing prevalence of different types of liver cancer demands for more innovative drugs and treatments. Moreover, the companies need to invest more in R&D activities for further expansion of their market shares and to build a strong foothold, globally.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
24
© TechSci Research
encouraging the R&D activities, which is propelling the market growth across the globe.
Sample Data - Snapshot Global Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion) CAGR (2020E-2025F) By Value: xx%
CAGR (2015-2019) By Value: xx%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
North America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Hepatocellular Carcinoma 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% 50.00% Cholangiocarcinoma
20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Liver Metasis
15.00% 15.00% 15.00% 15.00% 15.00% 15.00% 15.00% 15.00% 15.00% 15.00% 15.00%
Hepatoblastoma
10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
Angiosarcoma
5.00% 5.00% 5.00% 5.00% 5.00% 5.00% 5.00% 5.00% 5.00% 5.00% 5.00% Mexico Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Š TechSci Research
2015
Chemotherapy & Radiation 40.00% 40.00% 40.00% 40.00% 40.00% 40.00% 40.00% 40.00% 40.00% 40.00% 40.00% Targeted Therapy
30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00% 30.00%
Immunotherapy
20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00% 20.00%
Others
10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
25
Report Ordering
Report Name: GLOBAL LIVER CANCER THERAPEUTICS MARKET
BY CANCER TYPE, BY THERAPY, BY EQUIPMENT, BY AGE, BY FACTORS, BY ROUTE OF ADMINISTRATION, BY DISTRIBUTION CHANNEL, BY REGION, COMPETITION, FORECAST AND OPPORTUNITIES 2015 – 2025 License Type
Price
Single User License
$4450
Multi-User License
$5450
Custom Research License
$9450
© TechSci Research
To View Sample OR Purchase Report
26
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports •
Global Soft Tissue Sarcoma Market By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drug, Radiation Therapy), By Disease Type (Local Sarcoma, Regional Sarcoma, Metastatic Sarcoma), By End User (Hospitals, Oncology Center, Long Term Care Center), By Region, Forecast & Opportunities, 2025
•
Global Oncology Drugs Market By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025 TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Europe
54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com
© TechSci Research
Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
27